All web articles
There is something rotten in the kingdom of biomedical R&D. At least that’s what many have been saying for some years now. That the system is inefficient is probably difficult to dispute. It works...
Last updated 12 September 2014
A vaccine against cholera is being used on a large scale for the first time in Ethiopia by teams from the international medical organisation Médecins Sans Frontières/Doctors Without Borders (MSF)....
Last updated 26 August 2014
What is the status of research for Ebola vaccines and treatment ? We are in regular contact with researchers and we are aware that there are a handful of Ebola drugs and vaccines currently in early...
Last updated 13 August 2014
MSF expands treatment for people living with HIV, including the “Gold Standard” of treatment monitoring. Viral load testing shows the amount of HIV in the blood of a person living with the virus....
Last updated 6 August 2014
On World Hepatitis Day, organisations call on SA government: protect infants with HepB jab at birth & reduce patent barriers to HepB therapies
July 28, 2014, JOHANNESBURG—On World Hepatitis Day, 26 organisations and individuals from around the world have called on the South African Department of Health (DOH) and Department of Trade and Industry...
Last week, the emergency unit of Doctors Without Borders (MSF) in South Kivu ended the vaccination campaign in the district of Minova after reaching nearly 38,000 children and young people between...
Ninety-nine patients in Swaziland who successfully completed their treatment for drug-resistant tuberculosis have been presented with certificates by Médecins Sans Frontières (MSF) saying “I got...
Last updated 24 July 2014
Reduction in pricing still needed to ensure wider access to treatment
Ma Khin Khin* is a mother of four from Palauk township, around 130 kilometres south of Dawei in Myanmar’s Tanintharyi region. She is the very first MSF patient in Myanmar to receive the oral treatment,...
Last updated 23 July 2014
Melbourne, 21 July 2014 – High prices continue to represent a major barrier to affordable access of both new HIV medicines and viral load testing -- which is the best way to monitor whether treatment...